source
- bioQuad recalls OsteoDenx capsules after discovering undeclared milk, warning allergic consumersbioQuad Life Sciences announced a recall of two lots of its OsteoDenx dietary supplement capsules because they contain undeclared milk. The presence of milk, specifically lactoferrin derived from…
- Cellectis could cut 70% of workforce in shift to in vivo therapiesCellectis’ business transformation could cost around 160 global employees their jobs. The company has stopped enrollment in its two CAR T programs as it focuses on trials of its in vivo candidates.BioSpace · 4d ago↗ source